HCA Healthcare Inc. (HCA)
HCA Healthcare Is Too Healthy To Downgrade
HCA Healthcare remains a "Buy," supported by strong revenue growth and favorable demographic trends in healthcare demand. Despite some margin pressures from payer mix shifts, HCA's revenue per equivalent admission rose 6% and occupancy improved year-over-year. Management anticipates 2026 revenue growth to $77–$79.5 billion, though net income and EBITDA guidance have been revised slightly lower.
HCA Healthcare Sees Solid Demand as Exchange Headwinds Pressure 2026 Outlook
HCA Healthcare NYSE: HCA CFO Mike Marks said the hospital operator is navigating a changing policy environment in 2026 while continuing to see solid underlying demand for services outside of the health insurance exchanges.
HCA Healthcare, Inc. (HCA) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
HCA Healthcare, Inc. (HCA) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
Can Operational Resiliency Protect HCA's Long-Term Profitability?
HCA Healthcare's resiliency program is helping control costs amid payer pressures, potentially supporting long-term profitability and EBITDA growth.
HCA Healthcare, Inc. (HCA) Q2 2026 Earnings Call Transcript
HCA Healthcare, Inc. (HCA) Q2 2026 Earnings Call Transcript
HCA Q2 Earnings Beat on Strong Admissions, 2026 Outlook Revised
HCA tops Q2 EPS estimates on higher admissions and revenue per admission but trims parts of its 2026 guidance as higher expenses and weaker surgical volumes weigh on results.
HCA Healthcare Q2 Earnings Call Highlights
HCA Healthcare NYSE: HCA said its second-quarter performance reflected solid demand in several service lines and 11% growth in diluted earnings per share, but the company faced increased financial pressure as patients losing health insurance exchange coverage shifted largely into the uninsured population.
HCA (HCA) Reports Q2 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for HCA (HCA) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
HCA Healthcare (HCA) Q2 Earnings Surpass Estimates
HCA Healthcare (HCA) came out with quarterly earnings of $7.59 per share, beating the Zacks Consensus Estimate of $7.57 per share. This compares to earnings of $6.84 per share a year ago.
Will Higher Expenses Impact HCA Healthcare's Q2 Earnings?
HCA faces Q2 earnings uncertainty as rising expenses and fewer outpatient surgeries may offset admission growth.
HCA Healthcare's Warning Prices In All The Bad News (Upgrade)
HCA Healthcare is upgraded to "Buy" after recent underperformance, with shares now reflecting payer mix and policy headwinds. HCA's Q2 results beat expectations due to a $400 million one-time Medicaid payment, masking underlying margin compression from a worsening payer mix. Guidance was cut, with 2026 EPS now seen at $29–$30 (excluding windfall: ~$28), and free cash flow run-rate at ~$6 billion, reflecting persistent policy pressures.
HCA Healthcare Stock Falls as Uninsured Patients and Declining Surgeries Dent Outlook
HCA Healthcare stock falls after the hospital chain operator lowers its full-year profit outlook as uninsured patients rise in the second quarter.
